1 jan 2001 ano - Imatinib Mesylate
Descrição:
Results of a clinical trial show that the drug imatinib mesylate is effective against chronic myelogenous leukemia (CML), which targets a unique protein produced by the Philadelphia chromosome.
Adicionado na linha do tempo:
Data: